THE LAWSUIT: A class action securities lawsuit was filed against UroGen Pharma Ltd. that seeks to recover losses of shareholders who were adversely affected by alleged securities fraud between July 27, 2023 and May 15, 2025. WHY LEVI & KORSINSKY: Over the past 20 years, Levi & Korsinsky LLP has established itself as a nationally-recognized securities litigation firm that has secured hundreds of millions of dollars for aggrieved shareholders and built a track record of winning high-stakes cases. The firm has extensive expertise representing investors in complex securities litigation and a team of over 70 employees to serve our clients. For seven years in a row, Levi & Korsinsky has ranked in ISS Securities Class Action Services' Top 50 Report as one of the top securities litigation firms in the United States. 33 Whitehall Street, 17th FloorNew York, NY [email protected]: (212) 363-7500Fax: (212) 363-7171https://zlk.com/SOURCE: Levi & Korsinsky, LLPView the original press release on ACCESS Newswire